Analysis of Genetic Diversity of Envelope Genes Obtained from Patients of HIV Positive
DOI:
https://doi.org/10.17762/jaz.v44iS-5.1003Keywords:
Vaccine, Epidemiological, Human Immunodeficiency Virus, Disproportionate, DiagnosisAbstract
Human immunodeficiency virus type 1 (HIV-1) is the retrovirus of human origin that has been responsible for the global HIV/AIDS pandemic, resulting in the loss of more than 30 million lives over a span of forty years. The global prevalence of HIV infection is estimated to affect roughly 40 million individuals, therefore rendering it a significant public health issue. Due to the implementation of antiretroviral medication (ART), HIV has transitioned into a chronic condition that may be effectively controlled and maintained. Regrettably, the present state of affairs reveals a lack of both a vaccine and a cure for HIV/AIDS, notwithstanding the significant advancements achieved through antiretroviral therapy (ART) in enhancing the well-being of individuals living with HIV.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 MD Masum Raj

This work is licensed under a Creative Commons Attribution 4.0 International License.